PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
56.71
ESG score 50-60 - Below-average ESG territory. Benjamin Graham would scrutinize governance risks and regulatory exposure. Check Interest Coverage for financial stability.
54.44
Environmental score 50-60 - Below-average environmental territory. Benjamin Graham would scrutinize stranded asset risks and carbon liability exposure.
58.35
Social score 50-60 - Below-average social territory. Benjamin Graham would scrutinize reputational risks and potential litigation exposure from stakeholder issues.
57.34
Governance score 50-60 - Below-average governance territory. Benjamin Graham would scrutinize management entrenchment and potential agency costs.